Stock Rich List
#4636 on the rich list of 14,452 insiders

Jeffrey M. Leiden

Executive Chairman at Vertex Pharmaceuticals; Director at Odyssey Therapeutics. Based in Boston, Massachusetts.

$23.3M
in disclosed stock, −$729K (−3.03%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
Rank
4636th of 14,452
Companies held
2
Largest holding
VRTX, 78.7% of total
Latest SEC filing
May 11, 2026
Listed but not counted
$581K

What the $23.3M is made of

Holdings counted

All filings on SEC.gov
CompanyHow heldSharesPriceValueShare of totalReported
Vertex Pharmaceuticals VRTX
Common Stock
Directly34,797$520.66$18.1M77.8%Form 4, Feb 24, 2026
Odyssey Therapeutics ODTX
Common Stock
Directly270,198$18.34$5.0M21.3%Form 4, May 8, 2026
Vertex Pharmaceuticals VRTX
Common Stock
Indirectly (see filing footnote)440$520.66$229K1.0%Form 4, Feb 24, 2026

Share counts are the amounts Jeffrey M. Leiden reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.

Reported but not counted

These shares appear on Jeffrey M. Leiden's filings but are held for charities, by investment funds the insider manages, or could not be valued reliably. Insiders usually disclaim ownership of fund holdings beyond their personal stake.

CompanyHow heldSharesPriceValueShare of totalReported
Odyssey Therapeutics ODTX
Common Stock
Through Racing Beach Ventures LLC
Held by a company or fund the insider manages
31,661$18.34$581K—Form 4, May 11, 2026

Open-market trades, last 12 months

DateTradeCompanySharesPriceValueFiling
May 8, 2026BoughtODTX5,000$20.00$100KView
Dec 3, 2025SoldVRTX7,899$445.56$3.5MView
Dec 3, 2025SoldVRTX10,360$453.34$4.7MView
Dec 3, 2025SoldVRTX15,681$452.20$7.1MView
Dec 3, 2025SoldVRTX5,809$451.20$2.6MView
Dec 3, 2025SoldVRTX5,880$449.84$2.6MView
Dec 3, 2025SoldVRTX2,320$448.78$1.0MView
Dec 3, 2025SoldVRTX1,152$447.05$515KView
Dec 3, 2025SoldVRTX2,070$455.22$942KView
Dec 3, 2025SoldVRTX4,469$440.40$2.0MView
Dec 3, 2025SoldVRTX1,320$441.26$582KView
Dec 3, 2025SoldVRTX2,469$443.21$1.1MView
Dec 3, 2025SoldVRTX4,352$444.36$1.9MView
Nov 14, 2025SoldVRTX40$442.00$18KView
Nov 14, 2025SoldVRTX32,234$440.30$14.2MView
Nov 14, 2025SoldVRTX21,330$441.35$9.4MView
Nov 13, 2025SoldVRTX18,528$440.22$8.2MView
Nov 13, 2025SoldVRTX1,160$441.05$512KView

Nearby on the list

Full list
Nearby ranks
RankNameStock holdingsToday
4633Glen W. Hauenstein
President, Delta Air Lines. Atlanta, GA
$23.3M−$479K (−2.01%)
4634Aaron Freidin
Chief Financial Officer, GRAIL. Sunnyvale, CA
$23.3M+$609K (+2.68%)
4635Jason P. Wells
President & CEO, CenterPoint Energy. Houston, TX
$23.3M−$310K (−1.31%)
4636Jeffrey M. Leiden
Executive Chairman, Vertex Pharmaceuticals. Boston, MA
$23.3M−$729K (−3.03%)
4637Christopher R. Fenimore
EVP Finance CFO, Regeneron Pharmaceuticals. Tarrytown, NY
$23.3M−$560K (−2.35%)
4638Junyuan Jerry Wang
CEO, ANHEART THERAPEUTICS LTD., Nuvation Bio. New York, NY
$23.3M+$183K (+0.79%)
4639Kara Lynn Sprague
EVP & GM, Application Services, F5. Westminster, CO
$23.3M−$232K (−0.99%)

Other Vertex Pharmaceuticals insiders

All VRTX insiders

Questions

How much stock does Jeffrey M. Leiden own?

Jeffrey M. Leiden holds $23,301,928 in listed stock based on SEC filings and current prices, mostly Vertex Pharmaceuticals (VRTX). That ranks 4636th on the Stock Rich List.

Is this Jeffrey M. Leiden's net worth?

No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.

When did Jeffrey M. Leiden last buy or sell stock?

The most recent open-market trade on file is a purchase of 5,000 ODTX shares on May 8, 2026 at $20.00.